Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
26.05
+1.39 (5.64%)
At close: Apr 17, 2026
-5.72% (1Y)
| Market Cap | 287.14M +120.3% |
| Revenue (ttm) | 44.14M +830.4% |
| Net Income | 8.72M |
| EPS | 1.37 |
| Shares Out | 11.58M |
| PE Ratio | 18.05 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,789 |
| Average Volume | 731 |
| Open | 25.99 |
| Previous Close | 24.66 |
| Day's Range | 23.73 - 28.25 |
| 52-Week Range | 19.01 - 36.96 |
| Beta | -2.40 |
| RSI | 52.35 |
| Earnings Date | May 19, 2026 |